Study of Intravitreal Microplasmin in Relieving Vitreo-Macular Adhesion in Neovascular Age-related Macular Degeneration

NCT00996684 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Macular Degeneration

Interventions

DRUG: Microplasmin
DRUG: Placebo control

Sponsor

University of California, Los Angeles

Collaborators

[object Object]